Investigating the potential molecular players and therapeutic drug molecules in carfilzomib resistant multiple

Somnath Ghosal1, Subrata Banerjee1

  • 1School of Biological Sciences, Ramakrishna Mission Vivekananda Educational and Research Institute (RKMVERI), Kolkata, India.

Leukemia & Lymphoma
|June 14, 2022
PubMed

Insights

Understanding carfilzomib resistance in multiple myeloma (MM) is crucial. This study identified key genes, microRNAs, and pathways involved in MM drug resistance, offering potential new therapeutic targets.

Area of Science:

  • Hematological Malignancies
  • Cancer Genomics
  • Drug Resistance Mechanisms

Background:

  • Multiple myeloma (MM) is a common hematological malignancy with limited cure options due to acquired drug resistance.
  • Carfilzomib (Cfz) is a key therapy for MM, but resistance limits its efficacy.
  • The mechanisms underlying Cfz resistance in MM are poorly understood.

Purpose of the Study:

  • To investigate differentially expressed genes (DEGs), microRNAs (miRNAs), and transcription factors (TFs) in Cfz-resistant versus Cfz-sensitive MM cell lines.
  • To identify molecular pathways and potential therapeutic targets involved in Cfz resistance.
  • To gain new insights into the mechanisms of acquired Cfz resistance in MM.

Main Methods:

  • Analysis of microarray datasets from the Gene Expression Omnibus (GEO) database using GEO2R.
  • Identification of common DEGs via Venn diagrams.
  • Gene Ontology (GO) and pathway enrichment analysis using DAVID.
  • Construction of protein-protein interaction (PPI) networks using STRING and Cytoscape.
  • Investigation of genetic alterations using the COSMIC database.
  • Analysis of DEG-miRNA and DEG-TF interactions using mirDIP, TRRUST, and miRNet.
  • Drug-gene interaction analysis using DGIdb.

Main Results:

  • Several common DEGs were identified in Cfz-resistant MM.
  • PDGF, VEGF, and Wnt signaling pathways were significantly enriched, suggesting their role in MM progression.
  • hsa-mir-124-3p and hsa-mir-26a-5p were identified as potential targeting miRNAs for DEGs.
  • Potential therapeutic molecules, including dabrafenib, vemurafenib, and venetoclax, were identified.

Conclusions:

  • The study identified key molecular players and pathways contributing to carfilzomib resistance in multiple myeloma.
  • Specific miRNAs and signaling pathways (PDGF, VEGF, Wnt) are implicated in MM progression and drug resistance.
  • Identified drug molecules offer potential therapeutic strategies to overcome Cfz resistance in MM.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K